Product Specification
| Host |
Rabbit |
| Antigen |
Bcl-2 |
| Immunogen |
Synthetic Peptide |
| Accession |
P10415 |
| Clone Number |
SDT-005-24 |
| Antibody Type |
Rabbit mAb |
| Application |
WB, IHC-P |
| Reactivity |
Hu |
| Purification |
Protein A |
| Research Area |
Apoptosis |
| Concentration |
1 mg/ml |
| Molecular Weight |
26kDa |
| Conjugation |
Unconjugated |
| Physical Appearance |
Liquid |
| Storage Buffer |
PBS, 40% Glycerol, 0.05%BSA, 0.03% Proclin 300 |
| Stability & Storage |
12 months from date of receipt / reconstitution, -20 °C as supplied |
Dilution
| application |
dilution |
species |
| IHC-P |
1:500-1:2000 |
|
| WB |
1:5000 |
|
Background
Bcl-2 (B-cell lymphoma 2) is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis. It was the first apoptosis regulator identified in any organism. Bcl-2 is localized to the outer membrane of mitochondria, where it plays an important role in promoting cellular survival and inhibiting the actions of pro-apoptotic proteins. Damage to the Bcl-2 gene has been identified as a cause of a number of cancers, including melanoma, breast, prostate, chronic lymphocytic leukemia, and lung cancer, and a possible cause of schizophrenia and autoimmunity. It is also a cause of resistance to cancer treatments.